H.R. 6400 · 118th Congress

To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Stage
In committee
Introduced
2023-11-14
Latest action
2024-12-17 · Referred to the Subcommittee on Health.

Cosponsors (0)

No cosponsors are available.